Gainers
Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
According to Benzinga Pro, during Q2, National Beverage (NASDAQ:FIZZ) earned $39.28 million, a 27.0% increase from the preceding quarter. National Beverage's sales decreased to $283.16 million, a 9.16% change since Q1.
National Beverage (NASDAQ:FIZZ) reported quarterly earnings of $0.42 per share. This is a 17.65 percent decrease over earnings of $0.51 per share from the same period last year. The company reported $283.20 million in